GRANT PARK STRATEGIES

Lobbying for GRAIL, INC. · Biotechnology company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Keeping Congress informed about the efficacy of MCED testing, and exploring enhanced MCED coverage for at-risk populations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.